A Multi-Centre, Double Blind, Randomized, Placebo Controlled, Parallel Group Trial Investigating Methylprednisolone (MP) in Combination with Interferon-b-1a for the Treatment of Relapsing-Remitting Multiple Sclerosis (RRMS)

Authors
Publication date
1 January 2009
Publisher

Abstract

Item does not contain fulltex

    Similar works

    Full text

    thumbnail-image

    Available Versions

    NARCIS

    redirect
    Last time updated on 03/09/2017

    Radboud Repository

    redirect
    oaioai:repository.ubn.ru.nl:2066/...
    Last time updated on 06/09/2013